STOCK TITAN

Hoth Therapeutics to Participate in LD Micro's Zooming with LD, August 11th 8 AM PDT

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Hoth Therapeutics, Inc. (NASDAQ:HOTH) announced its participation in LD Micro's Zooming with LD on August 11, 2020, at 8 AM PDT. CEO Robb Knie will present an overview of the company's operations and recent advancements, particularly the development of a breath-based COVID-19 mobile testing device. This virtual presentation marks an important opportunity for Hoth to showcase its innovations in biopharmaceuticals, especially in treating dermatological disorders and COVID-19 vaccine development. For access, use the password HOTHwithLD.

Positive
  • None.
Negative
  • None.

NEW YORK, NY / ACCESSWIRE / August 10, 2020 / Hoth Therapeutics, Inc. (NASDAQ:HOTH), a biopharmaceutical company, announced today that the Company would be presenting at LD Micro's Zooming with LD on Tuesday, August 11th, 2020.

Robb Knie, Chief Executive Officer, will be presenting an overview of the company, as well as discussing recent developments and key highlights, including the company's just announced license to pursue the development of a breath-based COVID-19 mobile testing device.

The Hoth Therapeutics presentation will take place virtually over Zoom on Tuesday, August 11th, at 8 AM PDT.

To join the presentation, click here.
The password is HOTHwithLD

About LD Micro
LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into several influential events annually (Invitational, Summit, and Main Event). In 2015, LD Micro launched ldmicro.com as a portal to provide exclusive intraday information on the entire sector, including the first pure micro-cap index (LDMi) which covers stocks in North America with market capitalizations between $50 million to $300 million.

About Hoth Therapeutics, Inc.
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new generation therapies for dermatological disorders. Hoth's pipeline has the potential to improve the quality of life for patients suffering from indications including atopic dermatitis, chronic wounds, psoriasis, asthma and acne. Hoth has also recently entered into two different agreements to further the development of two different vaccine prospects to prevent or treat COVID-19. To learn more, please visit www.hoththerapeutics.com.

SOURCE: Hoth Therapeutics, Inc.



View source version on accesswire.com:
https://www.accesswire.com/601064/Hoth-Therapeutics-to-Participate-in-LD-Micros-Zooming-with-LD-August-11th-8-AM-PDT

FAQ

When is Hoth Therapeutics presenting at LD Micro's Zooming with LD?

Hoth Therapeutics will present on August 11, 2020, at 8 AM PDT.

Who is presenting for Hoth Therapeutics at the event?

Robb Knie, the Chief Executive Officer, will present on behalf of Hoth Therapeutics.

What key topics will be discussed during the Hoth Therapeutics presentation?

The presentation will cover the company's overview and recent developments, including a breath-based COVID-19 mobile testing device.

How can I join the Hoth Therapeutics presentation?

To join the presentation, click the link provided in the press release and use the password HOTHwithLD.

What type of company is Hoth Therapeutics?

Hoth Therapeutics is a clinical-stage biopharmaceutical company focusing on therapies for dermatological disorders.

Hoth Therapeutics, Inc.

NASDAQ:HOTH

HOTH Rankings

HOTH Latest News

HOTH Stock Data

5.81M
6.90M
0.93%
5.05%
4.54%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
NEW YORK